ClosedHealth & Human Services
Improving HIV/TB Policy Implementation in the KwaZulu Natal (KZN) Province in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGHCDC-RFA-GH21-2133
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $500,000 for Year 1, subject to the availability of funds.
The South African National Department of Health (NDoH) and the Departments of Health (DoHs) at provincial levels lead the public-sector HIV treatment and prevention efforts to achieve epidemic control. As of December 2019, there were 5.9 million people on antiretroviral therapy (ART) in the public sector, including 157,749 children (<15 years) and 4,411,868 adults. Despite strong health regulatory and policy interventions, and a clear agenda for quality health care and substantial annual expenditure for the public health system, shortcomings and barriers at decentralized levels of the public health system continue to risk access to adequate health care and ability to translate health policy into providing lifesaving interventions for citizens of South Africa (SA). As SA moves towards epidemic control, the PEPFAR program seeks to invest in more sustainable cost-efficient approaches to maintain the quality of HIV and TB services. This NOFO will fund a province-level DoH to translate policy to implementation, support data management and visualization, and address critical gaps in leadership and management, coordination, communication capacity building, supply chain and human resources for health (HRH) planning. Investing in stronger HIV/TB program oversight at the province level in KZN will support faster adoption and implementation of key policies and pave the path to a more efficient PEPFAR program in the long term.
CFDA Number
93.067
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
February 23, 2021
Close Date
April 26, 2021
Posted Date
February 23, 2021
Eligible Applicant Types
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Tags
HHS-CDC-CGHCFDA:93.067Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left